StockWatch
·
Healthcare Service Provider
Business Update24 Oct 2026, 06:10 pm

Tejnaksh Healthcare's Pflow Device Validated in Indian Journal of Urology

AI Summary

Tejnaksh Healthcare Ltd announced the publication of a research paper in the Indian Journal of Urology, validating its novel uroflowmetry device, Pflow™. The multicentric prospective study, involving 372 patients, demonstrated Pflow™'s agreement with conventional gravimetric uroflowmetry, supporting its utility as a convenient and patient-friendly solution. The publication, featuring Managing Director Dr. Ashish Rawandale-Patil and Director Dr. Preeti Rawandale as contributing authors, provides independent scientific validation for the technology. Pflow™ had previously gained recognition on Shark Tank India Season 2. This publication marks a significant milestone in translating indigenous medical innovation into evidence-based clinical practice.

Key Highlights

  • Pflow™ device validated in Indian Journal of Urology.
  • Study shows agreement with conventional uroflowmetry.
  • MD and Director are contributing authors to the paper.
  • Technology previously featured on Shark Tank India.
  • Publication provides independent scientific validation.